Prevalence of Hepatitis B in Random Bulgarian Blood Samples – A Single-Site Experience

1 Zampino R, Boemio A, Sagnelli C et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941-53. Search in Google Scholar

2 Hepatitis B – Annual epidemiological report for 2017. Stockholm: ECDC; 2019. Search in Google Scholar

3 Shepard CW, Simard EP, Finelli L et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-25. Search in Google Scholar

4 Argaw B, Mihret A, Aseffa A, et al. Seroprevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia. BMC infectious diseases. 2020;20(1):1-7. Search in Google Scholar

5 Hatzakis A, Van Damme A, Alcoin A. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat, 2013;20(12):1-20. Search in Google Scholar

6 Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14(1): 1-21. Search in Google Scholar

7 Hwang EW, Cheung R. Global Epidemiology of hepatitis B virus (HBV) infection. North American J Med Sci, 2011;4(1): 7-13. Search in Google Scholar

8 Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of agespecific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-2219. Search in Google Scholar

9 Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009;19:231-4. Search in Google Scholar

10 Akinyemiju, T. et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional and national level. JAMA Oncol. 2017;3,1683. Search in Google Scholar

11 Elgouhari HM, Abu-Rajab Tamimi TI, Carey WD. Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med 2008;75(12): 881-9. Search in Google Scholar

12 Todorova T, Tsankova G, Lodozova N. Hepatitis B infection in Eastern regions of Bulgaria. J of IMAB 2016;22(1):1033-1035. Search in Google Scholar

13 Kevorkyan A, Teoharov P, Lernout T, et al. Prevalence of HBV and HCV among outpatients in the Plovdiv region of Bulgaria, 2010-2011. J Med Virol. 2015; 87: 401-406. Search in Google Scholar

14 Chen CL, Yang JY, Lin SF, et al. Slow decline of hepatitis B burden in general population: results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol. 2015;63(2):354-63. Search in Google Scholar

15 Gheorghe L, Csiki IE, Iacob S, et al. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol. 2013; 25(1):56-64. Search in Google Scholar

16 Petrunov B, Kojouharova M, Teoharov P, et al. EU project interreg II: Seroepidemiology study of hepatitis C and B viral infections prevalence in Bulgaria and northern Greece. J Hepatol. 2002; 36: 138-139. Search in Google Scholar

17 Teoharov P, Kevorkian A. Molecular epidemiology of HBV and HCV in Bulgaria. VHPB country meeting in Bulgaria. 23-25.03.2011; Sofia. Bulgaria. Search in Google Scholar

18 Raimondo G, Allain JP, Brunetto MR et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652-7. Search in Google Scholar

19 Wang Q, Klenerman P, Semma N. Significance of anti-HBc alone serological status in clinical practice. Lancet Gastroenterol Hepatol. 2017;2(2):123-34. Search in Google Scholar

20 Wu T, Kwok RM, Tran TT. Isolated anti HBc: the relevance of hepatitis B core antibody: a review of new issues. Am J Gastroenterol 2017;112:1780-8. Search in Google Scholar

21 Zobeiri M. Occult Hepatitis B: Clinical Viewpoint and Management. Hepat Res Treat. 2013; 2013: 259148. Search in Google Scholar

22 Said Z. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17(15):1927-38. Search in Google Scholar

23 Giudice CL, Martinengo M, Pietrasanta P, et al. Occult hepatitis B virus infection: a case of reactivation receiving immunosuppressive treatment for allogenic bone marrow transplantation. Blood Transfus. 2008;6(1):46-50. Search in Google Scholar

24 Mitri MS, Cassini R, Bernardi M. Hepatitis B virus-related hepatocarcinogenesis: Molecular oncogenic potential of clear or occult infections. Eur J Cancer. 2010; 46: 2178-2186. Search in Google Scholar

25 Yuen MF, Wong DK, Lee CK et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis 2011; 52(5): 624-32. Search in Google Scholar